Celsion and Poly Pharm to Manufacture Celsion’s DNA-Based Vaccine

In an amendment to their existing contract manufacturing agreement, Celsian and Poly Pharm expand GEN-1 program collaboration to add clinical and commercial batches of investigational vaccine.